Golin, C. E.
Hill, L. M.
Ayangeakaa, S. D.
Allison, O.
Keshishian, T. H.
Michel, T.
Pulliam, A.
Woodley, A.
Amola, K.
Harding, C.
Hall, N.
Jacobs, T.
Jones, M.
Parrish, T.
Wiggins, D.
Riggins, L.
Lightfoot, A. F.
Choi, Y.
Navarro, I.
Frye, J.
Burns, C. M.
McKellar, M. S.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Assessing the Feasibility and Acceptability of a Mobile Medical Unit Program—(IFE4Her) to Enhance PrEP Awareness and Access Among Cis-gender Women in Low-Income Southeastern Communities: A Pilot Study
https://doi.org/10.1007/s10461-026-05134-1
Funding for this research was provided by:
Gilead Sciences
Article History
Accepted: 3 April 2026
First Online: 5 June 2026
Declarations
:
: Dr. Golin provided scientific consultation regarding medication adherence to Gilead Sciences, 3 years prior to the start of the study reported herein. Dr. McKellar has received separate grants from Gilead Sciences, which provide direct institutional support. No other authors have any competing interests.
: All study procedures were reviewed and approved by the institutional review boards of the University of North Carolina at Chapel Hill (IRB #22-1570) and Duke University (IRB Pro00110500). Post-visit client satisfaction surveys were conducted anonymously. To thank participants for their time, small gift bags containing self-care products (e.g. nail polish, hand cream) were offered.